1053533-67-7

Upstream product

• 185450-13-9 (4R,5S,6S,7R)-5,6-Bis-(2-methoxy-ethoxymethoxy)-4,7-bis-phenoxymethyl-[1,3]diazepan-2-one 
• 1053613-76-5 (2R,3S,4S,5R)-3,4-Bis-(2-methoxy-ethoxymethoxy)-1,6-diphenoxy-hexane-2,5-diamine 
• 185450-19-5 (4R,5S,6S,7R)-1,3-bis[[4-(methoxycarbonyl)phenyl]methyl]-5,6-bis[(2-methoxyethoxy)methoxy]-4,7-bis(phenoxymethyl)-1,3-diazepan-2-one 
• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 185450-05-9 2,5-diazido-3,4-O-isopropylidene-1,6-di-O-phenyl-2,5-dideoxy-D-iditol 
• 185450-07-1 2,5-diazido-1,6-di-O-phenyl-2,5-dideoxy-D-iditol 
• 185450-10-6 2,5-diazido-3,4-bis-O-[(2-methoxyethoxy)methyl]-1,6-di-O-phenyl-2,5-dideoxy-d-iditol 

Relevant academic research and scientific papers

Cyclic HIV-1 protease inhibitors derived from mannitol: Synthesis, inhibitory potencies, and computational predictions of binding affinities

Ten C2-symmetric cyclic urea and sulfamide derivatives have been synthesized from L-mannonic γ-lactone and D-mannitol. The results of experimental measurement of their inhibitory potencies against HIV-1 protease were compared to calculated free